You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

COVID-19, SARS-CoV-2 Vaccine

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Immunogenicity, Safety Trial (Phase II:SWIM816;SARS-Cov-2;, Phase II:SW-BIC-213;SARS-Cov-2;, PhaseIII:SWIM816;SARS-Cov-2;)

Not yet recruiting
  • Immunogenicity
  • Safety
  • Phase II:SWIM816;SARS-Cov-2;
  • +3 more
  • (no location specified)
Jun 18, 2023

COVID-19 Vaccine, COVID-19 Trial in Bangkok (50 µg Baiya SARS-CoV-2 Vax 2, Placebo)

Not yet recruiting
  • COVID-19 Vaccine
  • COVID-19
  • 50 μg Baiya SARS-CoV-2 Vax 2
  • Placebo
  • Bangkok, Thailand
    Queen Saovabha Memorial Institute
May 23, 2023

COVID-19 Trial (NVX-CoV2601 co-formulated Omicron XBB.1.5 SARS-CoV-2 rS vaccine, Prototype/XBB.1.5 Bivalent Vaccine (5 µg))

Not yet recruiting
  • COVID-19
  • NVX-CoV2601 co-formulated Omicron XBB.1.5 SARS-CoV-2 rS vaccine
  • Prototype/XBB.1.5 Bivalent Vaccine (5 µg)
  • (no location specified)
Aug 4, 2023

COVID-19 Trial in Wong Chuk Hang (SARS-CoV-2 DNA Vaccine (ICCOV))

Recruiting
  • COVID-19
  • SARS-CoV-2 DNA Vaccine (ICCOV)
  • Wong Chuk Hang, Hong Kong
    Gleneagles Hospital Hong Kong
Jun 16, 2023

A Study of the Effectiveness of Moderna COVID-19 Vaccine

Recruiting
  • SARS-CoV-2
  • COVID-19
  • mRNA-1273
  • Pasadena, California
    Kaiser Permanente Southern California
Jul 5, 2023

COVID-19, SARS-CoV-2 Trial in Seoul (QTP104 1ug, QTP104 5ug, QTP104 25ug)

Active, not recruiting
  • COVID-19
  • SARS-CoV-2
  • QTP104 1ug
  • +2 more
  • Seoul, Korea, Republic of
  • +1 more
May 24, 2023

COVID-19 Infection, COVID-19 Vaccine Adverse Reaction Trial in Seoul (LEM-mR203, Placebo)

Not yet recruiting
  • COVID-19 Infection
  • COVID-19 Vaccine Adverse Reaction
  • LEM-mR203
  • Placebo
  • Seoul, Korea, Republic of
    Seoul National University Hospital Clinical Trials Center
Sep 12, 2023

COVID-19 Pandemic, COVID-19 Vaccines Trial in Surabaya (Vaksin Merah Putih - UA SARS-CoV-2 (Vero Cell Inactivated) 5 µg,

Recruiting
  • COVID-19 Pandemic
  • COVID-19 Vaccines
  • Vaksin Merah Putih - UA SARS-CoV-2 (Vero Cell Inactivated) 5 µg
  • CoronaVac Biofarma COVID-1 9 Vaccine 3 µg
  • Surabaya, East Java, Indonesia
    Dr. Soetomo General Hospital
Jun 21, 2023

SARS-CoV-2 Vaccination on Cancer Patients Infected With

Recruiting
  • COVID-19 Infection
  • COVID-19 Vaccine
  • no intervention
  • Beijing, Beijing, China
    Sanhuan Cancer Hospital, Chaoyang District, Beijing(Cancer Hospi
Mar 7, 2023

COVID-19 Trial in Chengdu (LYB002V14, LYB002V14A, LYB002CA)

Active, not recruiting
  • COVID-19
  • LYB002V14
  • +2 more
  • Chengdu, Sichuan, China
    Affiliated Hospital of North Sichuan MedicalCollege
Jun 29, 2023

SARS-CoV-2 Infection, Varicella, Measles Trial in Shanghai (Inactivated SARS-CoV-2 vaccine coadministered with vricella vaccine,

Not yet recruiting
  • SARS-CoV-2 Infection
  • +4 more
  • Inactivated SARS-CoV-2 vaccine coadministered with vricella vaccine
  • +2 more
  • Shanghai, Shanghai, China
    Shanghai Municipal Center for Disease Control and Prevention
Jul 17, 2023

SARS-CoV-2 Trial in Bengbu (SARS-CoV-2 Variant (Omicron BA.5) mRNA vaccine, Saline solution)

Recruiting
  • SARS-CoV-2
  • SARS-CoV-2 Variant (Omicron BA.5) mRNA vaccine
  • Saline solution
  • Bengbu, Anhui, China
    First Affiliated Hospital Bengbu Medical College
Feb 26, 2023

COVID-19, Vaccine Reaction Trial in Chengdu (LYB001, CoronaVac)

Active, not recruiting
  • COVID-19
  • Vaccine Reaction
  • LYB001
  • CoronaVac
  • Chengdu, Sichuan, China
    Chengdu Xinhua Hospital Affiliated to North Sichuan Medical Coll
Jun 29, 2023

COVID-19 Trial (GamCovidVac-M vector vaccine for the prevention of COVID-19 with altered antigenic composition)

Not yet recruiting
  • COVID-19
  • GamCovidVac-M vector vaccine for the prevention of COVID-19 with altered antigenic composition
  • (no location specified)
Oct 4, 2023

COVID-19 Trial (GamCovidVac vector vaccine for the prevention of COVID-19 (with altered antigenic profile))

Not yet recruiting
  • COVID-19
  • GamCovidVac vector vaccine for the prevention of COVID-19 (with altered antigenic profile)
  • (no location specified)
Oct 4, 2023

Chronic Lymphocytic Leukemia, COVID-19 Infection Trial in Duarte (Biospecimen Collection, mRNA COVID-19 Vaccine, Synthetic

Not yet recruiting
  • Chronic Lymphocytic Leukemia
  • COVID-19 Infection
  • Biospecimen Collection
  • +2 more
  • Duarte, California
    City of Hope Medical Center
Jan 3, 2023

COVID-19 Trial in Guangzhou (the recombinant SARS-CoV-2 S-Trimer vaccine/inactivated SARS-CoV-2 vaccine)

Recruiting
  • COVID-19
  • the recombinant SARS-CoV-2 S-Trimer vaccine/inactivated SARS-CoV-2 vaccine
  • Guangzhou, Guangzhou, China
    The Fifth Affiliated Hospital of Guangzhou Medical University
Jan 28, 2023

COVID-19 Trial in Shang Qiu (low-dose Recombinant SARS-CoV-2 Vaccine (CHO cell), high-dose Recombinant SARS-CoV-2 Vaccine (CHO

Active, not recruiting
  • COVID-19
  • low-dose Recombinant SARS-CoV-2 Vaccine (CHO cell)
  • +2 more
  • Shang Qiu, He Nan, China
    Ning ling Center for Disease Control and Prevention
Jan 31, 2023

COVID-19 Vaccine Trial in Ciudad Autónoma de Buenos Aires (ARVAC-CG vaccine (recombinant protein vaccine against SARS-CoV-2))

Active, not recruiting
  • COVID-19 Vaccine
  • ARVAC-CG vaccine (recombinant protein vaccine against SARS-CoV-2)
  • Ciudad Autónoma de Buenos Aires, Argentina
    Unidad de Investigación Clínica Farmacocinética FP Clinical Phar
Dec 21, 2022

COVID-19 Trial in Manila, Putatan (SCB-2023 vaccine (trivalent), a recombinant SARS-CoV-2 trimeric S-protein subunit vaccine for

Not yet recruiting
  • COVID-19
  • SCB-2023 vaccine (trivalent), a recombinant SARS-CoV-2 trimeric S-protein subunit vaccine for COVID-19; intramuscular injection
  • SCB-2019 (monovalent), a recombinant SARS-CoV-2 trimeric S-protein subunit vaccine for COVID-19; intramuscular injection
  • Manila, Philippines
  • +2 more
Jun 21, 2023

Japan After Severe Acute Respiratory Syndrome Coronavirus 2

Not yet recruiting
  • SARS-CoV-2
    • Tokyo, Japan
      CMIC Co., Ltd
    Jun 6, 2023

    Covid19 Trial in Cypress (VXA-CoV2-1)

    Completed
    • Covid19
    • VXA-CoV2-1
    • Cypress, California
      WCCT
    Jan 17, 2023

    Severe Exacerbation of Severe Acute Respiratory Syndrome

    Active, not recruiting
    • SARS-CoV-2
      • Tokyo, Japan
        CMIC Co. Ltd.,
      Jun 5, 2023

      SARS-CoV-2 Trial (LVRNA009, 0.9%NaCl)

      Not yet recruiting
      • SARS-CoV-2
      • LVRNA009
      • 0.9%NaCl
      • (no location specified)
      Jan 11, 2023

      COVID-19 Trial in Wuhan (Recombinant SARS-CoV-2 Vaccine (CHO Cell) LYB001, ZF2001)

      Active, not recruiting
      • COVID-19
      • Recombinant SARS-CoV-2 Vaccine (CHO Cell) LYB001
      • ZF2001
      • Wuhan, Hubei, China
        Hubei Provincial Center for Disease Control and Prevention
      Jan 12, 2023